State Of Wyoming Macrogenics Inc Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.25 - $9.99 $63 - $279	-28 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.12 - $16.9 $32 - $67	4 Added 16.67%	28 $0
Q4 2021 Feb 11, 2022	BUY	$15.91 - $21.88 $190 - $262	12 Added 100.0%	24 $0
Q3 2021 Feb 11, 2022	SELL	$19.74 - $28.7 $98 - $143	-5 Reduced 29.41%	12 $0
Q2 2021 Feb 11, 2022	BUY	$20.49 - $35.63 $184 - $320	9 Added 112.5%	17 $0
Q1 2021 Feb 08, 2022	BUY	$18.99 - $33.2 $151 - $265	8 New	8 $0

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.